Official Title
Rapid Throughput Screening for Human COVID-19 Infection: A ECG Study
Brief Summary

The purpose of this study is to assess the ability of an artificial intelligence smartphone-enabled point of care ECG to detect COVID-19.

Terminated
COVID19
Eligibility Criteria

Inclusion Criteria:

- Adult males and females age 18 or greater.

- Undergoing COVID-19 testing by PCR.

- Willing and able to provide informed consent.

- Pregnant females (minimal risk study, no risk from ECG).

Exclusion Criteria:

- Unwilling or unable to provide informed consent.

Eligibility Gender
All
Eligibility Age
Minimum: 18 Years ~ Maximum: 89 Years
Countries
India
Spain
United Kingdom
United States
Locations

Mayo Clinic
Phoenix, Arizona, United States

Mayo Clinic
Jacksonville, Florida, United States

LSUHSC Shreveport
Shreveport, Louisiana, United States

Henry Ford Health System
West Bloomfield, Michigan, United States

Mayo Clinic
Rochester, Minnesota, United States

Hackensack Meridian Health
Hackensack, New Jersey, United States

Sri Jayadeva
Bengaluru, Karnataka, India

King Edward Memorial Hospital
Mumbai, Maharashtra, India

Gregorio Marañon Hospital
Madrid, Spain

Imperial College
London, England, United Kingdom

Elie F Berbari, MD, Principal Investigator
Mayo Clinic

NCT Number
MeSH Terms
COVID-19